Presented at ISPOR 2018, this poster is a real-world data analysis evaluating the time to glycemic control after initiation of basal insulin in type 2 diabetic patients.
Stacey J, Hilderbrand S, Stapff MP
TriNetX Inc., Cambridge, MA, USA
ISPOR 2018
“Diversity in clinical trials” is undoubtedly one of the hottest topics in the healthcare industry today and with good reason. Underrepresentation in clinical...
Chronic Lymphocytic Leukemia (CLL), a type of slow-growing cancer of the blood and bone marrow, accounts for 25-30 percent of all leukemia in the Western...
Powered By TriNetX MIT and BIDMC's study published by The Lancet introduces PRISM, a model for early pancreatic cancer risk, using a database of over 156...